The Experts below are selected from a list of 321 Experts worldwide ranked by ideXlab platform
Christos Pandis - One of the best experts on this subject based on the ideXlab platform.
-
MSDS LW2120 ---02-12-2010 (002).pdf
internal, 2017Co-Authors: Christos PandisAbstract:by a physician or poison control center. Never give anything by mouth to an unconscious person. Call a physician. General advice : When symptoms persist
Mollie R Cummins - One of the best experts on this subject based on the ideXlab platform.
-
Enabling health information exchange at a US Poison Control Center.
Journal of the American Medical Informatics Association : JAMIA, 2020Co-Authors: Mollie R Cummins, Barbara Insley Crouch, Guilherme Del Fiol, Pallavi Ranade-kharkar, Aly Khalifa, Andrew Iskander, Darren K. Mann, Matt Hoffman, Sidney N. Thornton, Todd L. AllenAbstract:OBJECTIVE The objective of this project was to enable Poison Control Center (PCC) participation in standards-based health information exchange (HIE). Previously, PCC participation was not possible due to software noncompliance with HIE standards, lack of informatics infrastructure, and the need to integrate HIE processes into workflow. MATERIALS AND METHODS We adapted the Health Level Seven Consolidated Clinical Document Architecture (C-CDA) consultation note for the PCC use case. We used rapid prototyping to determine requirements for an HIE dashboard for use by PCCs and developed software called SNOWHITE that enables Poison Center HIE in tandem with a Poisoning information system. RESULTS We successfully implemented the process and software at the PCC and began sending outbound C-CDAs from the Utah PCC on February 15, 2017; we began receiving inbound C-CDAs on October 30, 2018. DISCUSSION With the creation of SNOWHITE and initiation of an HIE process for sending outgoing C-CDA consultation notes from the Utah Poison Control Center, we accomplished the first participation of PCCs in standards-based HIE in the US. We faced several challenges that are also likely to be present at PCCs in other states, including the lack of a robust set of patient identifiers to support automated patient identity matching, challenges in emergency department computerized workflow integration, and the need to build HIE software for PCCs. CONCLUSION As a multi-disciplinary, multi-organizational team, we successfully developed both a process and the informatics tools necessary to enable PCC participation in standards-based HIE and implemented the process at the Utah PCC.
-
reference website use patterns of Poison Control Center specialists
IEEE International Conference on Healthcare Informatics, 2017Co-Authors: Jiawen Guo, Heather Bennett, Barbara Insley Crouch, Mollie R CumminsAbstract:The purpose of this pilot study was to describe web reference use patterns of Poison Control Center specialists using time tracking software. We analyzed two weeks of web site use data from Utah Poison Control Center (PCC) computers to describe patterns of reference web site use. We observed frequent use of webPoisonControl and Amazon. Specialists visited additional reference web sites that feature tools such as calculators websites provided the function of age calculation was visited sometime. In the future we plan to conduct a qualitative study to interview Specialists in Poison Information to get the rationales of visiting these webpages. This pilot study demonstrates the utility of time tracking software for better understanding reference utilization in the PCC setting.
-
AMIA - Public Health Data for Individual Patient Care: Mapping Poison Control Center Data to the C-CDA Consultation Note.
AMIA ... Annual Symposium proceedings. AMIA Symposium, 2017Co-Authors: Aly Khalifa, Guilherme Del Fiol, Mollie R CumminsAbstract:We are developing a new process of health information exchange supported collaboration that leverages the HL7 consolidated CDA standard through four document types (consultation note, history and physical, progress note and discharge summary). The focus of the present study is the C-CDA consultation note template that will be submitted from Poison Control Centers (PCC)s to emergency departments (EDs) with treatment recommendations. Specifically, we aimed to (i) create computable mappings between a Poison Control Center database and the C-CDA consultation note template; and (ii) assess the extent and nature of information types that successfully map to discrete data elements in a Poison Control Center database. The resulting template and mappings can be used to implement standards-based health information exchange between PCCs and EDs in the U.S. This is a part of the first formal effort to leverage health information exchange standards to support PCC-ED collaboration.
-
ICHI - Reference Website Use Patterns of Poison Control Center Specialists
2017 IEEE International Conference on Healthcare Informatics (ICHI), 2017Co-Authors: Jiawen Guo, Heather Bennett, Barbara Insley Crouch, Mollie R CumminsAbstract:The purpose of this pilot study was to describe web reference use patterns of Poison Control Center specialists using time tracking software. We analyzed two weeks of web site use data from Utah Poison Control Center (PCC) computers to describe patterns of reference web site use. We observed frequent use of webPoisonControl and Amazon. Specialists visited additional reference web sites that feature tools such as calculators websites provided the function of age calculation was visited sometime. In the future we plan to conduct a qualitative study to interview Specialists in Poison Information to get the rationales of visiting these webpages. This pilot study demonstrates the utility of time tracking software for better understanding reference utilization in the PCC setting.
-
public health data for individual patient care mapping Poison Control Center data to the c cda consultation note
American Medical Informatics Association Annual Symposium, 2016Co-Authors: Aly Khalifa, Guilherme Del Fiol, Mollie R CumminsAbstract:We are developing a new process of health information exchange supported collaboration that leverages the HL7 consolidated CDA standard through four document types (consultation note, history and physical, progress note and discharge summary). The focus of the present study is the C-CDA consultation note template that will be submitted from Poison Control Centers (PCC)s to emergency departments (EDs) with treatment recommendations. Specifically, we aimed to (i) create computable mappings between a Poison Control Center database and the C-CDA consultation note template; and (ii) assess the extent and nature of information types that successfully map to discrete data elements in a Poison Control Center database. The resulting template and mappings can be used to implement standards-based health information exchange between PCCs and EDs in the U.S. This is a part of the first formal effort to leverage health information exchange standards to support PCC-ED collaboration.
Chen-chang Yang - One of the best experts on this subject based on the ideXlab platform.
-
Datura and Brugmansia plants related antimuscarinic toxicity: an analysis of Poisoning cases reported to the Taiwan Poison Control Center
2018Co-Authors: Uyen Vy Doan, Dong-haur Phua, Bomar Mendez Rojas, Chen-chang YangAbstract:Introduction:Datura and Brugmansia plants, especially Datura species, have been used for their hallucinogenic effects in the United States and Europe; whereas Datura plants have been used as a traditional medicine in many Asian countries. This study was conducted to better understand the pattern and outcome of Datura/Brugmansia plant related Poisoning in Taiwan. Methods: This is a retrospective case series study of all cases with Datura/Brugmansia exposure reported to the Taiwan Poison Control Center between 1986 and 2015. Data for patients with relevant Poisoning were reviewed and abstracted. Logistic regression analysis was used to identify potential predictors of the severity of Poisoning; bivariate analysis was employed to assess the effectiveness of physostigmine in the treatment of Datura/Brugmansia Poisoning. Results: A total of 203 cases involving 114 Datura exposures and 89 Brugmansia suaveolens exposures were eligible for analysis. Using Datura/Brugmansia for a medicinal purpose by the patients without consulting Chinese medicine practitioners was the most common reason of Poisoning (81.2%); whereas only 2% of the patients were Poisoned after medicinal use associated with the prescription from Chinese medicine practitioners. None of the 203 patients had used Datura/Brugmansia plant for recreational purpose. Most frequently observed clinical effect was mydriasis (53.2%), followed by confusion (40%), tachycardia (35.5%), dry mouth (35.5%), dizziness (34%), dry skin (32.5%), and delirium (31%). Seventy-three cases (36%) had severe effects; none of them died. Misidentification of the plants and ingestion of plant parts other than flowers were positively associated with the severity of Poisoning. Forty patients (19.7%) received physostigmine therapy and patients receiving physostigmine had an earlier resolution of central nervous system toxicity than those who did not. Conclusions: Medicinal use without consulting Chinese medicine practitioners is the main reason for Datura/Brugmansia Poisoning in Taiwan. Consumption of parts other than flowers and misidentification of the plants predicted the severity of Poisoning in this study. Patients who received physostigmine appear to have earlier improvement in the central nervous system effects. No adverse events were reported from physostigmine administration.
-
acute hydrofluoric acid exposure reported to taiwan Poison Control Center 1991 2010
Human & Experimental Toxicology, 2014Co-Authors: Chen-chang Yang, Joufang Deng, Weijen Tsai, Jiin GerAbstract:BACKGROUND: Hydrofluoric acid (HF) is a dangerous chemical that can cause severe cutaneous burns as well as possible systemic toxicity. METHODS: We retrospectively analyzed all human HF exposure cases reported to the National Poison Control Center of Taiwan between 1991 and 2010. RESULTS: In this 20-year survey, 324 calls were identified, with a majority of dermal exposure (84%). Occupational exposure accounted for 80% of all cases, with workers in semiconductor industry (61%), cleaning industry (15%), chemical or metal industry (13%), and other industries (11%). Electrolyte imbalances were uncommon, hypocalcemia, hypomagnesemia, and hypokalemia were recorded in 8.6%, 1.2%, and 1.5% of all cases, respectively. Most cases (64%) of dermal exposure received antidotal treatment. Treatment modalities of dermal exposure included calcium gluconate soaking, 49.8%; intravenous calcium, 20.6%; and topical use of calcium gluconate gel, 13.9%. Twenty patients (7%) received surgery. Following HF exposure, the majority of patients presented with mild (56.5%) or moderate (36.7%) toxic effects. However, four patients were severely intoxicated; two patients died of HF-related dysrhythmia and shock. CONCLUSIONS: Significant symptomology may occur following HF exposure, and most of the HF exposure required hospitals evaluation. Calcium gluconate soaks appear to be effective in reducing local pain and tissue damage. Hyperkalemia should not be overemphasized as a common finding in HF exposure, hypokalemia tends to occur in cases of severe HF Poisoning. Language: en
-
antivenom therapy for crotaline snakebites has the Poison Control Center provided effective guidelines
Journal of the Formosan Medical Association, 2007Co-Authors: Yaochang Chen, Chen-chang Yang, Minhui Chen, Leemin Wang, Chuni Huang, Chenhsen Lee, David Hungtsang YenAbstract:Crotaline snakebites (Protobothrops mucrosquamatus and Trimeresurus stejnegeri) are a common medical emergency in Taiwan that can be effectively treated by a bivalent F(ab’)2 antivenom. We investigated the differences in the clinical outcomes of patients who received different therapeutic regimens of antivenom in a medical Center where clinical toxicologists followed the Poison Control Center (PCC) guidelines (medical group) and surgeons did not (surgical group). The medical records of inpatients with crotaline snakebites between 1991 and 2005 were reviewed and information on demographics, treatments, adverse effects of antivenom, and complications was abstracted and analyzed. A total of 179 patients (90 medical, 89 surgical) were eligible for study. There was no significant intergroup difference in baseline characteristics except that the dose of antivenom and the probability of antibiotic use were both higher in the surgical group (5.9 ± 4.2 vials vs. 2.7 ± 1.6 vials; 93% vs. 60%). Multiple logistic regression adjusting for age, gender, calendar year of envenomation, severity of envenomation, and antibiotic use did not disclose evidence of any difference in various clinical outcomes between medical and surgical patients. The lower dose of antivenom recommended by the PCC may be as effective and safe as the higher dose used in the surgical group for the treatment of crotaline snakebites. [J Formos Med Assoc 2007;106(12):1057–1062]
-
acute ethylene chlorohydrin Poisoning experience of a Poison Control Center
Clinical Toxicology, 2001Co-Authors: Joufang Deng, Chen-chang Yang, Weijen Tsai, Jiin GerAbstract:Background: Ethylene chlorohydrin (CAS 107-07-3), a chemical once used in hastening grape vine sprouting in Taiwan, has caused severe toxicity upon acute exposure. Although such use of ethylene chlorohydrin is now prohibited in Taiwan, Poisoning still occurs following its illegal use. Since data concerning human ethylene chlorohydrin Poisoning remain rare, we report our experience in treating acute ethylene chlorohydrin–Poisoned patients. Methods: A retrospective analysis was conducted to evaluate patients with ethylene chlorohydrin Poisoning reported to Taiwan Poison Control Center during 1985–1998. Results: Seventeen patients with ethylene chlorohydrin Poisoning were identified. There were 11 male and 6 female patients, ranging in age from 2 to 70 years (median 53 years). The intent of exposure was suicide in 5, accident in 9, and occupational exposure in 3 patients. Oral ingestion was the most common route of exposure (14 patients). Seven out of the 17 patients died within 24 hours due to metabolic aci...
Barbara Insley Crouch - One of the best experts on this subject based on the ideXlab platform.
-
Enabling health information exchange at a US Poison Control Center.
Journal of the American Medical Informatics Association : JAMIA, 2020Co-Authors: Mollie R Cummins, Barbara Insley Crouch, Guilherme Del Fiol, Pallavi Ranade-kharkar, Aly Khalifa, Andrew Iskander, Darren K. Mann, Matt Hoffman, Sidney N. Thornton, Todd L. AllenAbstract:OBJECTIVE The objective of this project was to enable Poison Control Center (PCC) participation in standards-based health information exchange (HIE). Previously, PCC participation was not possible due to software noncompliance with HIE standards, lack of informatics infrastructure, and the need to integrate HIE processes into workflow. MATERIALS AND METHODS We adapted the Health Level Seven Consolidated Clinical Document Architecture (C-CDA) consultation note for the PCC use case. We used rapid prototyping to determine requirements for an HIE dashboard for use by PCCs and developed software called SNOWHITE that enables Poison Center HIE in tandem with a Poisoning information system. RESULTS We successfully implemented the process and software at the PCC and began sending outbound C-CDAs from the Utah PCC on February 15, 2017; we began receiving inbound C-CDAs on October 30, 2018. DISCUSSION With the creation of SNOWHITE and initiation of an HIE process for sending outgoing C-CDA consultation notes from the Utah Poison Control Center, we accomplished the first participation of PCCs in standards-based HIE in the US. We faced several challenges that are also likely to be present at PCCs in other states, including the lack of a robust set of patient identifiers to support automated patient identity matching, challenges in emergency department computerized workflow integration, and the need to build HIE software for PCCs. CONCLUSION As a multi-disciplinary, multi-organizational team, we successfully developed both a process and the informatics tools necessary to enable PCC participation in standards-based HIE and implemented the process at the Utah PCC.
-
unintentional pediatric Poisoning exposures in an emergency department a comparison of Poison Control Center referrals and caregiver self referred visits
Pediatric Emergency Care, 2020Co-Authors: Amberly R Johnson, Casey R Tak, Michael B Mundorff, Jennifer Plumb, Barbara Insley CrouchAbstract:Objectives The purpose of this study is to describe the demographics and clinical characteristics of patients referred to a pediatric emergency department (ED) for unintentional Poisoning exposures by a Poison Control Center (PCC) compared with patients/caregivers who self-refer. Methods The electronic data warehouse at a pediatric hospital was queried from October 1, 2014, to September 30, 2015, for unintentional Poisoning-related ED visits and subsequent inpatient admissions. Eligible patients aged 18 years and younger were identified by International Classification of Diseases, Ninth Revision, Clinical Modification codes for pharmaceuticals, non-pharmaceuticalchemicals, fumes/vapors, foreign bodies, adverse food reactions, food Poisoning, and bites/stings. Referral classification (PCC referral vs self-refer) was determined by PCC and hospital medical records.Descriptive statistics were used to characterize the patient demographics and ED visits by referral classification and age group. Simple and multiple logistic regression models examined the individual and combined impact of demographic and clinical characteristics on self-referral. Results Of the 705 patients identified, 84.4% presented as caregiver/self-referred compared with PCC-referred. As compared with those who self-referred, a higher percentage of patients who contacted the PCC before ED presentation were white (93.9% [89.4-98.2%] vs 83.8% [80.7-86.7%]) and had commercial insurance (62.7% [51.5-69.5%] vs 53.0% [48.9-57.0%]). Pharmaceutical (71.9%) and chemical (14.0%) exposures were the most common exposure types for PCC-referred patients whereas foreign bodies (54.3%) were the most common for self-referred patients. The largest predictors of self-referral were age, insurance, and exposure type. Conclusions Among patients presenting at 1 pediatric ED, disparities with PCC utilization exist among age groups, racial identification, and Poison exposure type. Educational outreach interventions are needed to ensure optimal use of the PCC services by patients, caregivers, and health care professionals.
-
reference website use patterns of Poison Control Center specialists
IEEE International Conference on Healthcare Informatics, 2017Co-Authors: Jiawen Guo, Heather Bennett, Barbara Insley Crouch, Mollie R CumminsAbstract:The purpose of this pilot study was to describe web reference use patterns of Poison Control Center specialists using time tracking software. We analyzed two weeks of web site use data from Utah Poison Control Center (PCC) computers to describe patterns of reference web site use. We observed frequent use of webPoisonControl and Amazon. Specialists visited additional reference web sites that feature tools such as calculators websites provided the function of age calculation was visited sometime. In the future we plan to conduct a qualitative study to interview Specialists in Poison Information to get the rationales of visiting these webpages. This pilot study demonstrates the utility of time tracking software for better understanding reference utilization in the PCC setting.
-
the value of a Poison Control Center in preventing unnecessary ed visits and hospital charges a multi year analysis
American Journal of Emergency Medicine, 2017Co-Authors: Casey R Tak, Heather Bennett, Marty Malheiro, Barbara Insley CrouchAbstract:Abstract Objective The purpose of this study is to determine the economic value of the Utah Poison Control Center (UPCC) by examining its contribution to the reduction of unnecessary emergency department (ED) visits and associated charges across multiple years. Methods A multi-year (2009–2014) analysis of cross-sectional data was performed. Callers were asked what they would do for a Poison emergency if the UPCC was not available. Healthcare charges for ED visits averted were calculated according to insurance status using charges obtained from a statewide database. Results Of the 10,656 survey attempts, 5018 were completed. Over 30,000 cases were managed on-site each year. Using the proportion of callers who noted they would call 911, visit an ED, or call a physician's office, between 20.0 and 24.2 thousand ED visits were potentially prevented each year of the survey. Between $16.6 and $24.4 million dollars in unnecessary healthcare charges were potentially averted annually. Conclusions Compared to the cost of operation, the service UPCC provides demonstrates economic value by reducing ED visits and associated charges. As the majority of patients have private insurance, the largest benefit falls to private payers.
-
ICHI - Reference Website Use Patterns of Poison Control Center Specialists
2017 IEEE International Conference on Healthcare Informatics (ICHI), 2017Co-Authors: Jiawen Guo, Heather Bennett, Barbara Insley Crouch, Mollie R CumminsAbstract:The purpose of this pilot study was to describe web reference use patterns of Poison Control Center specialists using time tracking software. We analyzed two weeks of web site use data from Utah Poison Control Center (PCC) computers to describe patterns of reference web site use. We observed frequent use of webPoisonControl and Amazon. Specialists visited additional reference web sites that feature tools such as calculators websites provided the function of age calculation was visited sometime. In the future we plan to conduct a qualitative study to interview Specialists in Poison Information to get the rationales of visiting these webpages. This pilot study demonstrates the utility of time tracking software for better understanding reference utilization in the PCC setting.
David S Baker - One of the best experts on this subject based on the ideXlab platform.
-
cannabis and synthetic cannabinoid Poison Control Center cases among adults aged 50 2009 2019
Clinical Toxicology, 2021Co-Authors: Namkee G. Choi, Diana M. Dinitto, Nathan C Marti, David S BakerAbstract:Older (aged 50+) cannabis users are growing in numbers, but research on Poison Control Center (PCC) cases has not focused on them. In this study, we examined: (1) changing trends in cannabis forms ...
-
management site and level of health care for cannabis and synthetic cannabinoid related Poison Control Center cases involving older adults 2016 2019
Drug and Chemical Toxicology, 2021Co-Authors: Namkee G. Choi, Diana M. Dinitto, Nathan C Marti, David S BakerAbstract:Increasing numbers of older adults use cannabis and cannabis-derived products that can have adverse effects. This study examined management site and level of healthcare services for older adult Poison Control Center cases involving cannabis products. Using the American Association of Poison Control Centers' (PCC) National Poison Data System, 2016-2019, we extracted the 3109 cases aged 50+ for which cannabis was the only or primary substance. Multinomial logistic regression models were fit to examine associations between specific cannabis forms and management/care site (on site [mostly at home], at a healthcare facility [HCF], or no follow-up due to referral refusal or leaving against medical advice) and level of healthcare services for cases managed at a HCF. The results show that between 2016 and 2019, PCC cannabis cases involving older adults increased twofold, largely due to cases of cannabidiol, edibles, and concentrated extracts. Plant form and synthetic cannabinoid cases declined substantially. Compared to plant forms, synthetic cannabinoid cases had 4.22 (95% CI = 2.59-6.89) greater odds of being managed at, rather than outside, a HCF and 2.17 (1.42-3.31) greater odds of critical care unit admission. Although e-cigarette cases, compared to plant form cases, had lower odds of being managed at a HCF, HCF-managed e-cigarette cases had 3.43 greater odds (95% CI = 1.08-10.88) of critical care unit admission. Synthetic cannabinoid cases also had 1.86 (95% CI = 1.03-3.35) greater odds of no follow-up, and the presence of a secondary substance was also a significant factor. Stricter regulations for listing chemical ingredients and providing safety guidelines are needed for cannabis-derived products.